Corey L.Zarse


Chicago + 1.312.269.4399

Corey Zarse focuses his practice on financial services firms, particularly private investment funds, investment advisers, investment companies, and broker-dealers. He supports financial services clients as they navigate complex regulatory requirements in their daily business operations and in situations that may arise in special circumstances.

Corey counsels clients on complex matters relating to regulatory, compliance, securities offerings, and transactions, including mergers, acquisitions, and joint ventures. He has extensive experience advising clients on the regulatory aspects of investment fund formation, operation, and structure. His practice also includes advising on responding to regulatory issues raised by the SEC, counseling advisers and fund officers regarding compliance and operational issues, organizing and registering investment companies, preparing for and responding to SEC examinations, and other matters relating to the operation of investment funds.

Prior to joining Jones Day, Corey handled sophisticated transactions involving multibillion fund formations such as those for Summit Partners in the formation of its $3.3 billion Summit Partners Growth Equity Fund IX; Thompson Street Capital Partners in the formation of its $1.15 billion Thompson Street Capital Partners V; Nautic Partners, LLC on the $1.5 billion formation of Nautic Partners IX; and Peak Rock Capital in the formation of its $1.3 billion Peak Rock Capital Fund II.


  • Morgenthaler Private Equity forms MPE Partners III, L.P. and its parallel fundsJones Day represented Morgenthaler Private Equity in its fundraise and formation of MPE Partners III, L.P. and its parallel funds (collectively, "MPE") with $420.1 million in capital commitments.
  • Gilde Healthcare V raises €416 million for its venture and growth capital fundJones Day represented Gilde Healthcare in connection with the establishment of Gilde Healthcare V, a venture & growth capital fund that invests in digital and home health, medtech, diagnostics, research tools and instruments, and therapeutics.
  • Concord Health Partners forms AHA Innovation Development FundJones Day represented Concord Health Partners LLC in connection with the formation of the AHA Innovation Development Fund, LP, a fund focused on investing in early-stage healthcare companies that provide products, services, and solutions to hospitals and health systems.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.